Nerve Regeneration After Peripheral Nerve Injury, Are Flavonoids the Answer? A Scoping Review

Review Article

Austin J Clin Neurol. 2024; 11(1): 1165.

Nerve Regeneration After Peripheral Nerve Injury, Are Flavonoids the Answer? A Scoping Review

Nieto L1*; Hernández AM2; López-Sarasty L2; Camacho-Domínguez L3

1Department of Plastic Surgery, Fundación Santa Fe de Bogotá, Colombia

2Pontifical Javeriana University, Colombia

3Department of Plastic Surgery, Pontifical Javeriana University, Colombia

*Corresponding author: Nieto L Department of Plastic Surgery, Fundación Santa Fe de Bogotá. Cl. 123 #7A -60, Bogotá, Colombia. Tel: +57310 7631576 Email: luis.nieto@fsfb.org.co

Received: March 06, 2024 Accepted: April 18, 2024 Published: April 25, 2024

Abstract

Flavonoids are polyphenol compounds of plants origin with antioxidant, anti-inflammatory, immunomodulatory, and analgesic functions, among others. Peripheral nerve lesions represent a burden for patients and a high cost for the health systems. Although a diversity of surgical management is available, adjuvant therapies are required to improve regeneration time and prevent atrophy of the affected target organs. This review aims to synthesize the available information on the use of flavonoids in peripheral nerve regeneration. A review of the available literature was carried out, demonstrating that flavonoids are a therapeutic alternative that could favor axonal regeneration. However, clinical studies are required since the available works reviewed are experimental in murine models, and their extrapolation to humans is essential.

Keywords: Flavonoids; Peripheral nerve injury; Nerve regeneration; Schwann cell

Abbreviations: PNL: Peripheral Nerve Lesions; 7,8 DHF: 7,8-Dihydroxyflavone; BDNF: Neurotrophin Brain-Derived Neurotrophic Factor; trkB: Tropomyosin Receptor Kinase B; GDNF: Glia-Derived Neurotrophic Factor; BYHWD: Buyang Huanwu; GAP-43: Proteins Growth-Associated Protein 43; EGCG: Epigallocatechin-3-Gallate; NGF: Neural Growth Factor; SC: Schwann cells; Nrf2: Nuclear Factor Erythroid 2-Factor 2

Introduction

Peripheral Nerve Lesions (PNL) are a group of entities that include sensory and motor nerve disorders. It has been estimated that 20 million people are affected in the US, generating an average cost of $150,000 annually. This type of injury is associated with high disability depending on the location and type of injury, leading even to loss of the limb function. Among the most frequent mechanisms of injury are trauma, compression, iatrogenic lesions, metabolic and infectious alterations. It should be noted that trauma is the most frequent, with a prevalence of 1.3-2.8% [1,2].

There are different therapeutic options for its treatment, in which microsurgical reconstruction stands out. However, it must be considered that up to a third of the patients who receive the surgical intervention will have alterations in their functionality and quality of life related to incomplete recovery. Taking this into account, the need for new treatments that promote cell regeneration is imperative [3]. Among the available options, mesenchymal cells and bone marrow transplantation aim to promote cell differentiation processes, metabolic activity, and growth factors for post-injury repair [4,5]. Recently, flavonoids have been described as a novel tool to promote regeneration [6-10].

Flavonoids are secondary metabolites of plant-based polyphenols, which promote pigmentation and herbal reproduction and are found primarily in fruits and vegetables [11,12]. Multiple benefits have been attributed to them since they have anti-inflammatory, immunomodulatory, and antioxidant effects, among others [12]. They are used in neurodegenerative diseases and as an adjuvant in central nervous system lesions. When discussing its use in nerve regeneration after a peripheral nerve injury, there is literature available describing its positive association, thus being a possible treatment option [6-10]. Considering the above, this review aims to synthesize the available information about the use of flavonoids in peripheral nerve regeneration.

Methods

A search of the literature was performed in the electronic databases PUBMED, EMBASE, COCHRANE, and LILACS with the terms "flavonoidal" OR "flavonoid" OR "flavonoids" OR "flavonoidic" OR "flavonoids" [MeSH Terms] OR "flavonoid" AND ("peripheral nerve injuries"[MeSH Terms] OR ("nerve regeneration"[MeSH Terms]. No discrimination was made based on study design or publication date. The articles found were extracted to Rayyan software for later review, and duplicates were eliminated.

Eligibility Criteria

Articles included in this review had to use any molecule belonging to the flavonoid family as an intervention to assess its effect on peripheral nerve regeneration. When evaluating nerve regeneration, articles could use any measurement method, including different motor, sensory, and morphological evaluation tools. Articles had to be in Spanish or English. Articles that did not describe the methods used or for which the complete manuscript could not be obtained were excluded.

Article Selection Process

Three reviewers independently evaluated titles and abstracts of the manuscripts based on the eligibility criteria. Once discriminated, selection differences were resolved in a group reunion. Only those articles that the three reviewers approved were included. Subsequently, the complete manuscripts were analyzed, and data extraction was made. As a guide during the identification, review, and selection process, the PRISMA - ScR guidelines were followed [13].

Data Extraction

Three reviewers independently assessed the full articles and extracted the title, authors, year of publication, study design, country, and research objectives. Additionally, the type of flavonoid used in the intervention, the study subjects, the methodology and tools for measuring nerve regeneration, results, conclusions, and limitations of each study were recorded. All this information was recorded in Excel © 2022 Microsoft.

Results

Selection of Sources of Evidence

After searching for articles in the electronic databases, 49 articles were obtained. Six duplicate articles were found. Subsequently, the review of titles and abstracts was carried out by applying the eligibility criteria, where 25 papers were selected that met all the characteristics. After reviewing the complete articles, those that did not have the entire manuscript or did not report the method for evaluating regeneration were excluded. Finally, 23 articles remained for analysis (Figure 1) [10,14-35].

Citation: Nieto L, Hernández AM, López-Sarasty L, Camacho-Domínguez L. Nerve Regeneration After Peripheral Nerve Injury, Are Flavonoids the Answer? A Scoping Review. Austin J Clin Neurol. 2024; 11(1): 1165.